抗血小板的

Antiplatelet therapy is recommended for symptomatic patients. 推薦抗血小板治療癥狀性患者。

Conclusion: The antiplatelet drugs utilization needs further standardization. 結論：臨床需進一步規(guī)范使用抗血小板藥物。

Evidence based case report Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy? 原發(fā)性腦出血患者是否應該進行抗血小板或抗凝治療?

Antiplatelet Therapy for Secondary Prevention of Cardiovascular Events: More "Advanced" Drug, More Perfect? 心血管事件的二級預防:抗血小板治療藥物越“先進”越完美嗎?

Title:Can antiplatelet prophylaxis reduce the incidence of hepatic artery thrombosis after liver transplantation? 抗血小板預防可否減少肝移植術后肝動脈栓塞的發(fā)生率?